Here are five things to know:
1. Northland Securities assumed coverage of Stryker shares yesterday.
2. Northland issued an “outperform” rating.
3. They gave a $109 price target on Stryker shares.
4. Argus recently reiterated a “buy” rating at $110 price target.
5. Stryker’s vice president Katherine Ann Owen sold 18,575 shares recently in a $1.7 million transaction.
More articles on orthopedic devices:
LDR gets “Outperform” rating—5 key notes
Spinal Kinetics M6 disc replacement: Good results 2 years postop
Allegheny Health Network incorporates MAKOplasty
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
